Cargando…

The Important Role of Immunotherapies in Acute Myeloid Leukemia

Detalles Bibliográficos
Autor principal: Greiner, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947250/
https://www.ncbi.nlm.nih.gov/pubmed/31766688
http://dx.doi.org/10.3390/jcm8122054
_version_ 1783485506775941120
author Greiner, Jochen
author_facet Greiner, Jochen
author_sort Greiner, Jochen
collection PubMed
description
format Online
Article
Text
id pubmed-6947250
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69472502020-01-13 The Important Role of Immunotherapies in Acute Myeloid Leukemia Greiner, Jochen J Clin Med Editorial MDPI 2019-11-22 /pmc/articles/PMC6947250/ /pubmed/31766688 http://dx.doi.org/10.3390/jcm8122054 Text en © 2019 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Greiner, Jochen
The Important Role of Immunotherapies in Acute Myeloid Leukemia
title The Important Role of Immunotherapies in Acute Myeloid Leukemia
title_full The Important Role of Immunotherapies in Acute Myeloid Leukemia
title_fullStr The Important Role of Immunotherapies in Acute Myeloid Leukemia
title_full_unstemmed The Important Role of Immunotherapies in Acute Myeloid Leukemia
title_short The Important Role of Immunotherapies in Acute Myeloid Leukemia
title_sort important role of immunotherapies in acute myeloid leukemia
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947250/
https://www.ncbi.nlm.nih.gov/pubmed/31766688
http://dx.doi.org/10.3390/jcm8122054
work_keys_str_mv AT greinerjochen theimportantroleofimmunotherapiesinacutemyeloidleukemia
AT greinerjochen importantroleofimmunotherapiesinacutemyeloidleukemia